Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Kymera Therapeutics Inc (KYMR)

Kymera Therapeutics Inc (KYMR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Insider Sale: Director at $KYMR (KYMR) Sells 2,500 Shares

Pamela Esposito, a director at $KYMR ($KYMR), sold 2,500 shares of the company on 12-02-2024. We received data on the trade from a recent SEC filing. This was a sale of approximately 100.0% of their shares....

KYMR : 40.66 (+3.88%)
Kymera Therapeutics to Participate in Upcoming December Investor Conferences

KYMR : 40.66 (+3.88%)
Kymera Therapeutics to Participate in Upcoming November Investor Conferences

KYMR : 40.66 (+3.88%)
Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update

KYMR : 40.66 (+3.88%)
Kymera Therapeutics Announces Dosing of First Participant in Phase 1 Clinical Trial of KT-621, a First-in-Class Oral STAT6 Degrader, for the Treatment of TH2 Immuno-Inflammatory Diseases

KYMR : 40.66 (+3.88%)
Kymera Therapeutics to Report Third Quarter 2024 Financial Results on October 31

KYMR : 40.66 (+3.88%)
Kymera Therapeutics Announces Three Scientific Presentations at the EORTC-NCI-AACR 2024 Symposium

KYMR : 40.66 (+3.88%)
Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application for KT-621, a First-in-Class, Oral STAT6 Degrader

KYMR : 40.66 (+3.88%)
Stocks Undercut by Chip Stock Weakness

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.32%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.04%. US stocks Monday...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
ARM : 132.15 (+0.04%)
MRO : 28.55 (-1.28%)
AMD : 119.21 (+0.28%)
MU : 90.12 (+3.48%)
LRCX : 71.79 (+0.81%)
Stocks Turn Lower as Chip Stocks Slide

The S&P 500 Index ($SPX ) (SPY ) is down -0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.29%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.08%. US stocks today are mixed, with the...

$SPX : 5,930.85 (+1.09%)
SPY : 591.15 (+1.20%)
$DOWI : 42,840.26 (+1.18%)
DIA : 428.54 (+1.24%)
$IUXX : 21,289.15 (+0.85%)
QQQ : 518.66 (+0.87%)
ZNH25 : 108-310s (+0.33%)
ARM : 132.15 (+0.04%)
MU : 90.12 (+3.48%)
NVDA : 134.70 (+3.08%)
MRO : 28.55 (-1.28%)
LRCX : 71.79 (+0.81%)

Barchart Exclusives

Is It Time to Sell This Second-Fiddle AI Stock Before 2025?
Bank of America has cut its rating on AMD while lowering its price target. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar